AI English summary of an SEC filing — figures as filed
The company said it announced leadership changes on March 13, 2025, with Brian C. Evanko serving as President and Chief Operating Officer starting March 31, 2025. He has served as Executive Vice President and Chief Financial Officer since January 2024.
Key points
AI summaryThe company said it announced leadership changes on March 13, 2025, with Brian C. Evanko serving as President and Chief Operating Officer starting March 31, 2025. He has served as Executive Vice President and Chief Financial Officer since January 2024.
Cigna said the People Resources Committee approved compensation for Mr. Evanko to reflect his new role on March 10, 2025. Effective March 31, 2025, his base salary is $1,100,000, his 2025 EIP annual target is $2,200,000, and his 2026 LTI target is $6,700,000.
The company said Ann M. Dennison will serve as Executive Vice President and Chief Financial Officer effective March 31, 2025, with a base salary of $800,000, a 2025 EIP target of $1,100,000 and a 2026 LTI target of $3,500,000. A transitional strategic performance share grant with a grant value of $750,000 for the 2025–2027 performance period was also approved.
The company reaffirmed that it expects full-year 2025 consolidated adjusted income from operations of at least $29.50 per share. It also reaffirmed Evernorth pre-tax adjusted income from operations of at least $7.2 billion and Cigna Healthcare pre-tax adjusted income from operations of at least $4.1 billion.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Brian C. Evanko Named President and COO
The company said it announced leadership changes on March 13, 2025, with Brian C. Evanko serving as President and Chief Operating Officer starting March 31, 2025. He has served as Executive Vice President and Chief Financial Officer since January 2024.
Source · Based on the filing body and exhibits
Evanko Compensation Terms
Cigna said the People Resources Committee approved compensation for Mr. Evanko to reflect his new role on March 10, 2025. Effective March 31, 2025, his base salary is $1,100,000, his 2025 EIP annual target is $2,200,000, and his 2026 LTI target is $6,700,000.
Source · Based on the filing body and exhibits
Ann M. Dennison Named CFO and Compensation
The company said Ann M. Dennison will serve as Executive Vice President and Chief Financial Officer effective March 31, 2025, with a base salary of $800,000, a 2025 EIP target of $1,100,000 and a 2026 LTI target of $3,500,000. A transitional strategic performance share grant with a grant value of $750,000 for the 2025–2027 performance period was also approved.
Source · Based on the filing body and exhibits
Reaffirms 2025 Full-Year Adjusted Income From Operations Outlook
The company reaffirmed that it expects full-year 2025 consolidated adjusted income from operations of at least $29.50 per share. It also reaffirmed Evernorth pre-tax adjusted income from operations of at least $7.2 billion and Cigna Healthcare pre-tax adjusted income from operations of at least $4.1 billion.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…